| Document Date: 2012-12-13 18:06:00
Open Document File Size: 379,81 KBShare Result on Facebook
City Newcastle upon Tyne / San Diego / Cambridge / / Company Astex Therapeutics Ltd. / / Country United Kingdom / / / Facility A Pike / Northern Institute / Paul O’Gorman Building / / IndustryTerm in vitro systems / serum free media / / MedicalCondition NOD/SCID / Ba/F3-TEL/FGFR3 Xenograft tumours / ve Multiple Myeloma / TEL/FGFR3 Murine B-cell Tumours / cancer / Multiple Myeloma / disease / KMS11 Xenograft tumours / positive multiple myeloma line / In KMS11 tumours / MS / FGFR3 positive multiple myeloma models / +ve Multiple Myeloma / positive Multiple Myeloma / Tumour / tumours / / Organization Northern Institute for Cancer Research / / Person Murray / V / / / PublishedMedium Cancer Research / / Technology X-Ray / Apoptosis / /
SocialTag |
Development of Inhibitors of the Fibroblast Growth Factor Receptor (FGFR) Kinase Using a Fragment Based Approach[removed]M S Squires, G Saxty, C W Murray, V Berdini, G A Ward, M Batey*, A Peasland*,D Miller, S J Rich, A C